Compare WIT & IFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WIT | IFF |
|---|---|---|
| Founded | 1945 | 1833 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.3B | 19.8B |
| IPO Year | 2000 | 2010 |
| Metric | WIT | IFF |
|---|---|---|
| Price | $1.94 | $81.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $89.09 |
| AVG Volume (30 Days) | ★ 12.3M | 1.8M |
| Earning Date | 04-16-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.42% | 2.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | N/A |
| Revenue This Year | $10.20 | N/A |
| Revenue Next Year | $4.98 | $3.11 |
| P/E Ratio | ★ $16.59 | $119.68 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.80 | $59.14 |
| 52 Week High | $3.13 | $84.45 |
| Indicator | WIT | IFF |
|---|---|---|
| Relative Strength Index (RSI) | 39.84 | 64.66 |
| Support Level | $1.80 | $68.50 |
| Resistance Level | $2.53 | $84.17 |
| Average True Range (ATR) | 0.15 | 2.11 |
| MACD | -0.03 | 0.38 |
| Stochastic Oscillator | 2.52 | 97.80 |
Wipro is a multinational IT services provider based in Bengaluru, India. The company pivoted into the IT space in the 1980s and grew into one of the largest Indian IT consulting companies during the dot-com boom. Nowadays, Wipro leverages its offshore outsourcing model to derive a significant portion of its revenue from North America and Europe.
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations and partners with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrance producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest it in a deal expected to close in 2027.